NanoPass Technologies Ltd

Based in Israel, NanoPass Technologies Ltd specializes in advanced intradermal delivery solutions, focusing on the MicronJet™ product platform for efficient vaccine and drug delivery. NanoPass Technologies Ltd is an innovative company dedicated to developing intradermal delivery systems. Founded in 2000 in Israel by Shuki Yeshurun, the company has undergone strategic developments in its operations, particularly with its focus on advanced delivery systems. It has raised a total of USD 4.

00 mn, with its latest funding round led by AWZ Ventures. NanoPass has completed 5 investment deals and currently holds a valuation of USD 6. 00 mn. NanoPass Technologies specializes in advanced intradermal delivery solutions, with a focus on the MicronJet™ product platform.

This flagship offering utilizes Micro Electro Mechanical Systems (MEMS) technology to create a distinctive hollow pyramid design, enabling precise, safe, and efficient delivery of vaccines and drugs through the skin. The 0. 6mm MicronJet™ is notable for being the smallest intradermal delivery device to receive FDA clearance. The company's products primarily address the need for pain-free delivery methods in therapeutic and aesthetic medical applications, targeting healthcare providers and pharmaceutical companies as key clients.

Geographically, NanoPass operates in leading markets worldwide, expanding its global reach through partnerships with pharmaceutical distributors and institutions focused on enhancing patient care. NanoPass generates revenue through B2B transactions with pharmaceutical companies, healthcare providers, and distributors. The company’s revenue model is structured around the direct sale of its MicronJet™ devices, which are adopted for clinical use in various therapeutic and vaccine delivery applications. Pricing is aligned with the value proposition of providing virtually pain-free delivery solutions tailored to the needs of institutional buyers.

Revenue streams are bolstered by strategic partnerships that support regulatory approvals and enhance product distribution in targeted markets. The company is focused on expanding its product offerings and global market reach. Future products are expected to include enhanced versions of the MicronJet™ technology, with planned launches in the next 12 to 18 months. NanoPass aims to enter new markets in North America and Europe by 2025, utilizing recent funding of USD 4.

00 mn to support these initiatives. This funding will enhance product development and strengthen distribution channels to ensure successful market entry.